SCHEMBL27675582

SCHEMBL27675582

O=C(OC1=CC=CC=CN1)[C@@H]1CCCN1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 1/20 0.34
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
DPP4 P27487 3/20 0.33
DPP8 Q6V1X1 2/20 0.33
SCN4A P35499 1/20 0.33
DPP9 Q86TI2 1/20 0.33
ELANE P08246 1/20 0.32
MBTD1 Q05BQ5 1/20 0.31
L3MBTL3 Q96JM7 1/20 0.31
HTR2C P28335 3/20 0.31
NOS2 P35228 2/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
PSMB8 P28062 1/20 0.30
HTR2B P41595 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28194974 0.79 KMT2A (0.47) ELANE
SCHEMBL28050425 0.78 SLC6A1 (0.45) CYP2D6NOS2TSHR
SCHEMBL27861553 0.73
SCHEMBL28816547 0.72
SCHEMBL5729552 0.70 NPC1 (0.31)
SCHEMBL27718907 0.69 FABP7 (0.36)
Proline SCHEMBL27675583 0.68 MEN1 (0.40) DPP4DPP8SCN4ADPP9ELANE
SCHEMBL23356900 0.68 DPP4 (0.49) CYP3A4CYP2D6CYP1A2CYP2C19DPP4
SCHEMBL4447785 0.68 DPP4 (0.49) CYP3A4CYP2D6CYP1A2CYP2C19DPP4
SCHEMBL2016284 0.68 DPP4 (0.49) CYP3A4CYP2D6CYP1A2CYP2C19DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1953763-A Y4 selective receptor agonists for therapeutic intervention 7TM PHARMA AS (DK) 2007-04-25 CN claimed
CN-105228642-A Compositions and methods for inhibiting tumor cells by inhibiting transcription factor ATF5 TRUSTEES OF COLUMBIA UNVERSITY IN THE CITY OF NEW YORK 2016-01-06 CN disclosed
CN-101035568-A Combination therapy using transferrin fusion proteins comprising GLP-1 BIOREXIS PHARMACEUTICAL CORP (US) 2007-09-12 CN disclosed
CN-1953763-A Y4 selective receptor agonists for therapeutic intervention 7TM PHARMA AS (DK) 2007-04-25 CN disclosed
CN-1933848-A Y2 selective receptor agonists for therapeutic intervention 7TM PHARMA AS (DK) 2007-03-21 CN disclosed